Emerging research has shown that nutraceuticals in aquafeed can delay the onset and progress of clinical signs of amoebic gill disease (AGD) in farmed Atlantic salmon.
Indonesia’s aquafeed producers – be they industrial players or farmers who produce feed independently – are increasingly looking towards the use of local and sustainable alternatives to fish meal and soy.
Shrimp fed diets containing FeedKind, a novel microbial protein produced by Calysta, have been shown to be more resistant to Vibrio parahaemolyticus – the source of early mortality syndrome (EMS).
Heidi Kuehnle, founder and CEO of Kuehnle AgroSystems, has developed an innovative, patented means for producing natural astaxanthin – one of the key ingredients in feeds for species including Atlantic salmon and vannamei shrimp.
